
Share on:
The seven largest public orthopedic companies spent $2.3+ billion on R&D in 2019 and 2020, an expense that was about 7% of their combined sales in 2019 and 8% in 2020, according to our estimates. Click the infographic to see R&D investments by dollars and percent of sales for DePuy Synthes, Stryker, Zimmer Biomet and more.
RELATED ARTICLES
On a Mission to Create Equity in Worldwide Orthopedic Care
May 28 2025 , BONEZONE Editors
Sawbones Granted FDA Qualification of ENDPOINT Virtual Pullout Test
May 20 2025 , Julie A. Vetalice
Croom Medical Launches TALOS 3D-Printed Tantalum Implants
May 20 2025 , Julie A. Vetalice